📄 Cross-examination of Gregory Matheson (part 4) — Thursday, May 4, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\4\CROSS-EXAMINATION-OF-GREGORY-M.DOC
TRIAL
▲ Day 67 of 167

Cross-examination of Gregory Matheson (part 4)

Witness: Gregory Matheson
Examiner: Robert Blasier
Called by: Prosecution • Date: Thursday, May 4, 1995 • Utterances: 478
Defense attorney Robert Blasier used a detailed slide presentation to systematically challenge LAPD criminalist Gregory Matheson's interpretation that the type B blood found under Nicole Brown Simpson's fingernails could have come from a degraded BA sample — which would implicate O.J. Simpson. Blasier walked Matheson through the scientific literature on EAP degradation, ultimately getting the witness to concede that the banding pattern he observed does not match the degradation route described in any published article, and that Matheson never retested the sample despite having the opportunity.
1 (The following proceedings were held in open Court:)
2 MR. BLASIER:

Your Honor, I would like to show one of the People's charts.

3 THE COURT:

All right. Mr. Blasier, which chart is this?

4 MR. BLASIER:

I think it's 302.

5 THE COURT:

No. Well, when it comes down, we'll take a look at it.

6 MR. BLASIER:

Mr. Matheson, you've seen that chart before. You've testified about it, correct?

7 MR. MATHESON:

Yes, I have.

8 MR. BLASIER:

And in that chart, it's indicated that--by the way, who prepared this chart?

9 MR. MATHESON:

It was prepared by the D.A.'s office.

10 MR. BLASIER:

You didn't prepare it, did you?

11 MR. MATHESON:

No, I did not.

12 MR. BLASIER:

Item no. 42 is the sample taken from the area under Nicole Brown Simpson, correct?

13 MR. MATHESON:

Yes, it is.

14 MR. BLASIER:

And one of the arguments that the Prosecution is using to say that your test results on the nail scrapings are something other than they are--

15 THE COURT:

Counsel, you need to rephrase that question.

16 MR. BLASIER:

Okay.

17 THE COURT:

All right. And for the record, this is People's 202, the chart.

18 MR. BLASIER:

In your report that you prepared after your analysis, you determined that item 42 was inconclusive, correct?

19 MR. MATHESON:

That's correct.

20 MR. BLASIER:

And what's the scientific definition or meaning of the term "inconclusive"?

21 MR. MATHESON:

Inconclusive to me means that there's not a conclusive decision or conclusive statement that can be made about the results.

22 MR. BLASIER:

Isn't it--doesn't it mean scientifically that you can make no statements about the source of the stain when it's inconclusive?

23 MR. MATHESON:

Well, I would not--I don't report an inconclusive result. So yes, I would not make a statement about the source based on an inconclusive result.

24 MR. BLASIER:

Now, but in this case, you're asking to make some conclusion about the source of the stain, of 42, even though it's an inconclusive, aren't you?

25 MR. GOLDBERG:

That misstates the evidence.

26 THE COURT:

That's argumentative, the way it's phrased.

27 MR. BLASIER:

Now, on your final report, when you reported your findings on 84-A and B, does your report say B asterisk?

28 MR. MATHESON:

No, it does not.

29 MR. BLASIER:

It says B, doesn't it?

30 MR. MATHESON:

Yes.

31 MR. BLASIER:

It says B for both the left hand and the right hand, doesn't it?

32 MR. MATHESON:

That's correct.

33 MR. BLASIER:

Now, do I understand that it's your position now from your testimony that you're asking that--or you're stating that the B is something other than a B?

34 MR. GOLDBERG:

That misstates the testimony too.

35 THE COURT:

Overruled.

36 MR. MATHESON:

I'm not saying that the B that I observed is anything other than what I am seeing, and that's the two bands in the B area. I'm merely stating that there is possible other explanations in addition to it being a type B.

37 MR. BLASIER:

Now, all of the other serological results that you've testified to, you testified that your results are accurate or you believe they're accurate, correct?

38 MR. GOLDBERG:

That also misstates the testimony.

39 THE COURT:

Overruled.

40 MR. MATHESON:

I believe all of my results are accurate.

41 MR. BLASIER:

Is there any other tests that you did where you got a reading or a result that you reported that you're asking us to accept as being inaccurate except that one?

42 MR. MATHESON:

I'm not stating that this one is inaccurate. I'm just stating that there is an alternate explanation for what I'm seeing on the gel.

43 MR. BLASIER:

Okay. So it looks like a B, doesn't it?

44 MR. MATHESON:

Yes, it does.

45 MR. BLASIER:

And what you're saying is that in your opinion, sometimes something else can look like a B that isn't a B, correct?

46 MR. MATHESON:

That's correct.

47 MR. BLASIER:

And that's a BA, correct?

48 MR. MATHESON:

That's correct.

49 MR. BLASIER:

But in this case, you saw a B, didn't you?

50 MR. MATHESON:

Yes, I did.

51 MR. BLASIER:

Now, how long has the Los Angeles Police Department been using the EAP system?

52 MR. MATHESON:

I believe that we have been running EAP as part of a system for--well, it was in existence when I started doing my testing, which was in 1982, and I believe it had been being used for a few years before that, two to four, six, something like that.

53 MR. BLASIER:

Can you give me just a real rough estimate of the number of cases that you've worked on where you've done an EAP test?

54 MR. MATHESON:

I would like to check my record and see if I made an estimation of that.

55 MR. BLASIER:

Sure.

56 (Brief pause.)
57 MR. MATHESON:

Okay. The chart that I prepared of tests that I run did not include the EAP. I can give you a rough estimate based on some of the other markers that I've done.

58 MR. BLASIER:

Okay.

59 MR. MATHESON:

And I would say that I have run somewhere between, oh, probably 14-, 1500 and about 2,000 items for that marker.

60 MR. BLASIER:

And an EAP type B is a fairly common type, isn't it?

61 MR. MATHESON:

I believe it is, yes.

62 MR. BLASIER:

So can you give us--do you know what percentage of the population is a B?

63 MR. MATHESON:

I would have to check another chart that I have.

64 MR. BLASIER:

Why don't you do that.

65 (The witness complies.)
66 MR. MATHESON:

According to our statistics that we use, it's approximately 50 percent of the general population.

67 MR. BLASIER:

And would it be fair to infer from that that of the approximately 1500 times you've done this test, roughly half of them would come back EAP B?

68 MR. MATHESON:

That's correct.

69 MR. BLASIER:

And have you testified in Court before about EAP results that have come back as a B?

70 MR. MATHESON:

Yes, I have.

71 MR. BLASIER:

And of course, in these approximately 750 cases, I assume you've written reports that have said, "I tested it. Looks like an EAP B to me," correct?

72 MR. MATHESON:

Yes.

73 MR. BLASIER:

In all of those reports, do you write down, "you know, it could be a BA"?

74 MR. MATHESON:

Not in all those reports, no. I do include that disclaimer when the EAP is a source of elimination or exclusion in a sample.

75 MR. BLASIER:

Have you testified in Court where an EAP B happens to be the type of the suspect and also the evidence you've tested, that it's an EAP type B without giving that disclaimer?

76 MR. MATHESON:

Like I just mentioned, I will put that it's a B unless it's an exclusion of some type.

77 MR. BLASIER:

Can I take that as a yes, you have so testified in cases that an EAP B result is a B when it incriminates a Defendant without saying that it could have been a BA?

78 MR. MATHESON:

Yes.

79 MR. BLASIER:

Now, as I understand your argument that this B that you found is something other than a B is based on two things; one, scientific literature?

80 THE COURT:

Mr. Blasier, would you--

81 MR. BLASIER:

I'm sorry?

82 THE COURT:

Would you rephrase that question, please, when you start out, "your argument that".

83 MR. BLASIER:

You testified yesterday that one of the reasons you're here to say that a b--that this B might have been a BA is because of the scientific literature, correct?

84 MR. MATHESON:

That's one of the things, yes.

85 MR. BLASIER:

And one of the other things is that--that you're using--that you testified to is that because sample 42 has the same findings or similar findings as 85 and since 42 appears to have come from the victim, then, therefore, the fingernail--the blood under the fingernails may have come from the victim as well. Have I got that right?

86 MR. MATHESON:

No. I believe the other reason that I use is personal experience in both this case and other cases.

87 MR. BLASIER:

Did you not use the example of 42 as well?

88 MR. MATHESON:

Yes, but I don't think that was your question on this particular instance.

89 MR. BLASIER:

Had you ever written any papers or published anything on EAP systems?

90 MR. MATHESON:

No, I have not.

91 MR. BLASIER:

Have you ever kept track of your research or your case work on EAP systems where you have this phenomenon developed when you have a B that might be something other than a B?

92 MR. MATHESON:

No, I have not.

93 MR. BLASIER:

So is it fair to say that your personal experience is based on anecdotal information?

94 MR. GOLDBERG:

It's argumentative as to "anecdotal."

95 THE COURT:

Overruled.

96 MR. MATHESON:

It's based on experiences I've had in casework.

97 MR. BLASIER:

Now I would like to start the slide presentation we talked about.

98 (Brief pause.)
99 MR. BLASIER:

And this will be 1141. This will be slide a and this will be a through G, your Honor.

100 THE COURT:

All right.

101 (Deft's 1141 for id = slides a through z)
102 MR. BLASIER:

Now, Mr. Matheson, when you conduct an EAP test, the final product of that test is what's called an electrophoretogram, correct?

103 MR. MATHESON:

It's a photograph of the electrophoresis run, yes.

104 MR. BLASIER:

And that's a picture of where the bands ended up on the gel after you did the test, correct?

105 MR. MATHESON:

That's correct.

106 MR. BLASIER:

Now, the EAP system, as you testified before, has three possible alleles or results that you can get in terms of the component that might come from one parent or the other, correct?

107 MR. MATHESON:

That's correct.

108 MR. BLASIER:

And that's either an A, a B or a C?

109 MR. MATHESON:

That's correct. There are--

110 MR. BLASIER:

I'm sorry.

111 MR. MATHESON:

Other common types, yes.

112 MR. BLASIER:

There are a couple rare types that are almost never found?

113 MR. MATHESON:

There are many rares, yes.

114 MR. BLASIER:

For all practical purposes, the field is limited to an A, a B or a C?

115 MR. MATHESON:

Correct.

116 MR. BLASIER:

Now, if someone inherited the B characteristic from both parents, then they would appear as a B?

117 MR. MATHESON:

That's correct.

118 MR. BLASIER:

And if someone interpreted the a characteristic from both parents, they would be an A?

119 MR. MATHESON:

That's true.

120 MR. BLASIER:

And if someone inherited an a from mom and a B from dad, they would be a BA?

121 MR. MATHESON:

That's correct.

122 MR. BLASIER:

And that's basically how it works, and the same thing would apply if you got a c from one of your parents?

123 MR. MATHESON:

Yes.

124 MR. BLASIER:

Now, the way you determine what an EAP type is is by looking at the bands on the gel to see where they stopped when you turned the current off, correct?

125 MR. MATHESON:

That's one of the factors in this, yes.

126 MR. BLASIER:

And you've seen--you've seen these slides before. We looked at these yesterday. Do you recall that?

127 MR. MATHESON:

Yes, I do.

128 MR. BLASIER:

And the slide that's up there now is a--is your electrophoretogram for run number 7310, correct?

129 MR. MATHESON:

Yes, it is.

130 MR. BLASIER:

And does that appear to be an accurate picture of that slide?

131 MR. MATHESON:

Yes.

132 MR. BLASIER:

Now, I might indicate that--we talked about this yesterday--sometimes the slides when you scan them in the computer don't pick up all of the nuances of the banding patterns, correct?

133 MR. MATHESON:

Well, that's correct, yes. Some things may not show up as well being projected like this and looking at the original photograph.

134 MR. BLASIER:

And we have the original photographs, so we can look at those at some point, correct?

135 MR. MATHESON:

Yes. I have them here.

136 MR. BLASIER:

Now--

137 MR. BLASIER:

Could we go to the next slide, please?

138 MR. BLASIER:

Now, I've drawn a box around a band--or I'm sorry--a lane in the middle of this electrophoretogram, correct?

139 MR. MATHESON:

Yes.

140 MR. BLASIER:

And this is what's called a standard. In other words, you knew what this was before you tested it, correct?

141 MR. MATHESON:

That's correct.

142 MR. BLASIER:

And you knew this was a BA?

143 MR. MATHESON:

That's true.

144 MR. BLASIER:

And the reason you do this is so that you can look at your unknown evidence that you're testing and--well, let me rephrase that. The reason you do this is because you want to see if the test worked okay. If this comes back the way you expected it to, that's a good indication the test worked?

145 MR. MATHESON:

That's one of the reasons, yes.

146 MR. BLASIER:

Now, this particular lane in the middle, this BA standard, came back the way it's supposed to, didn't it?

147 MR. MATHESON:

That's a typical looking BA, yes.

148 MR. BLASIER:

And--

149 MR. BLASIER:

Let's go to the next slide. This slide's c? C.

150 MR. BLASIER:

Now, I've drawn boxes around the various bands in that standard, and there are four bands, correct?

151 MR. MATHESON:

Yes, there are.

152 MR. BLASIER:

Go to the next slide, please.

153 MR. BLASIER:

Now, I've removed the picture from the background so it's a little bit easier to see. Those four bands are called b-1, a-1, b-2 and a-2, aren't they?

154 MR. MATHESON:

That's one of the designations for them, yes.

155 MR. BLASIER:

Can we go to the next slide, please?

156 MR. BLASIER:

Now, I've colored them in so that they're a little bit easier to distinguish. Now, if someone is an A, they're going to have two bands located at a-1 and a-2, correct?

157 MR. MATHESON:

Yes.

158 MR. BLASIER:

That's what you would expect to see?

159 MR. MATHESON:

That's correct.

160 MR. BLASIER:

If somebody is a B, you would expect to see two bands, one at b-1, one at b-2, correct?

161 MR. MATHESON:

Yes.

162 MR. BLASIER:

Go to the next slide, please.

163 MR. BLASIER:

Now, you--would you agree that if you saw that particular banding pattern depicted on slide F, that's a BA?

164 MR. MATHESON:

It's a rough graphical demonstration of it. It has a little bit of a problem in that it doesn't indicate the intensity differences in the bands.

165 MR. BLASIER:

Okay. Well, let me ask you about that. The--you talked about how the intensity of a band might affect the reading, correct?

166 MR. MATHESON:

It definitely does affect the reading, yes.

167 MR. BLASIER:

Now, c bands, which are not on this diagram, correspond in position to the B bands, don't they?

168 MR. MATHESON:

Yes, they do.

169 MR. BLASIER:

So that you can have a c with a banding pattern that--that is at the same space as is on the electrophoretogram as the B, correct?

170 MR. MATHESON:

That's correct. The two c bands run the same distance as the B bands.

171 MR. BLASIER:

And one of the ways that you tell the difference between a c and a B is by the differences in intensities of the various--of those two bands, correct?

172 MR. MATHESON:

Well, not one of the ways. "the way"--

173 MR. BLASIER:

"the way."

174 MR. MATHESON:

--is to tell the difference--look at the difference in the intensities or brightnesses of the bands.

175 MR. BLASIER:

Now, if you're talking about comparing an a and a B, however, none of those bands overlap, do they?

176 MR. MATHESON:

No, they do not.

177 MR. BLASIER:

So if your universe is limited to an a or a B, band intensity is irrelevant, correct?

178 MR. MATHESON:

No, that's not true.

179 MR. BLASIER:

What is the effect of band intensity on telling the difference between an a and a B?

180 MR. MATHESON:

Well, as far as telling the difference between the two--I'm sorry if I misunderstood your last question--it doesn't make a difference. It does make a difference when evaluating the sample and whether or not you call it, because--

181 MR. BLASIER:

Okay.

182 MR. MATHESON:

--you expect to see intensities in certain ways, as far as the result goes.

183 MR. BLASIER:

But as far as distinguishing an a from a B, it's irrelevant?

184 MR. MATHESON:

The intensities, that's correct.

185 MR. BLASIER:

Now, may we have the next slide, please?

186 MR. BLASIER:

Now, this is the pattern you would expect to see with a type B, correct?

187 MR. MATHESON:

Again, except for the fact that the b-2 is the more intense and would be larger and the b-1 is less intense.

188 MR. BLASIER:

Okay. But in terms of relative position, that's correct, isn't it?

189 MR. MATHESON:

That's true.

190 MR. BLASIER:

And the next slide, please?

191 THE COURT:

Hold on. This one is which?

192 MR. BLASIER:

That was G. This is h.

193 THE COURT:

All right. You need to, for the purpose of the record, let me know which one you're bringing up.

194 MR. BLASIER:

Okay.

195 MR. BLASIER:

And correspondingly, the column on the right, that's what an a would look like in terms of the position of the bands?

196 MR. MATHESON:

Yes, that's true.

197 MR. BLASIER:

Next slide, please. That's i.

198 MR. BLASIER:

Now, Mr. Matheson, this is a picture of the electrophoretogram that contains the fingernails; is it not?

199 MR. MATHESON:

Yes, it is.

200 MR. BLASIER:

Now, this has a lot of little dots and things on it that are extraneous results that sometimes come up in these tests, correct?

201 MR. MATHESON:

That's correct. The dots, the round dots that you see are not related to the EAP or the information from the samples.

202 MR. BLASIER:

And the scientific term for that is schmutz, isn't it?

KEY QUOTE
203 MR. MATHESON:

Actually, I don't think I've heard that term, but--

204 MR. BLASIER:

Okay. Mr. Scheck told me. Next slide, please. This is j.

205 MR. BLASIER:

Now, I've circled or boxed three lanes of that electrophoretogram, correct?

206 MR. MATHESON:

Yes, you have.

207 MR. BLASIER:

And the lane on the right of the box is your BA standard lane, correct?

208 MR. MATHESON:

That's correct.

209 MR. BLASIER:

And the two lanes next to it to the left are 84-A and 84-B, correct?

210 MR. MATHESON:

Yes.

211 MR. BLASIER:

Next slide, please.

212 MR. BLASIER:

Now I'm going to isolate just those three bands, correct?

213 MR. MATHESON:

Yes.

214 MR. BLASIER:

And that's slide K. Now let's go to l.

215 MR. BLASIER:

I'm going to make it a little bit bigger so we can look at it a little more carefully.

216 MR. BLASIER:

Now let's go to m.

217 MR. BLASIER:

Now, I've drawn boxes around the bands in their approximate positions, correct?

218 MR. MATHESON:

The approximate position, yes.

219 MR. BLASIER:

Now, let me--let me back up a little bit. When we saw the picture of the electrophoretogram, it looked like it was a little bit bowed down at the sides, correct?

220 MR. MATHESON:

Well, it was quite a bit bowed at one point, yes.

221 MR. BLASIER:

Quite a bit. And that happens sometimes as a function of the way the test is done, correct?

222 MR. MATHESON:

Yes.

223 MR. BLASIER:

It doesn't invalidate the test, does it?

224 MR. MATHESON:

No.

225 MR. BLASIER:

Because you can--you can adjust the bow to figure out where the bands are and essentially straighten it out in essence to figure out which bands you're looking at, can't you?

226 MR. MATHESON:

You can sometimes, yes.

227 MR. BLASIER:

Now, the bands that I boxed there are slightly out of line with the standard because the electrophoretogram was bowed a little bit, correct?

228 MR. MATHESON:

Yes.

229 MR. BLASIER:

And would you agree that the boxes that I've put around the bands are--are the bands that you read when you did this test?

230 MR. GOLDBERG:

Well, that's vague as to "the bands that you read."

231 THE COURT:

Overruled. Do you understand the question, sir?

232 MR. MATHESON:

Yes.

233 THE COURT:

All right.

234 MR. MATHESON:

In the--

235 MR. BLASIER:

Now--I'm sorry?

236 MR. MATHESON:

In the case of 84-A and 84-B, those are two bands that are visible that are not the only parts of that area that are taken into account.

237 MR. BLASIER:

But those are the bands that are there?

238 MR. MATHESON:

That's correct.

239 MR. BLASIER:

And next slide, please. Now, we've taken the background out to give it--so you can see it a little bit better. And that's N. Now let's do m.

240 MR. GOLDBERG:

Your Honor, I am going to object at this point on the grounds previously stated.

241 THE COURT:

Noted.

242 MR. GOLDBERG:

I thought we were going to be clarified.

243 THE COURT:

You were going to ask a question regarding the alignment of the boxes.

244 MR. BLASIER:

Oh, I'm sorry. I thought I did.

245 MR. BLASIER:

Mr. Matheson, on--

246 MR. BLASIER:

This is slide o.

247 MR. BLASIER:

I've indicated that the bands from the fingernails are bands b-1 and b-2, and that's the bands that we saw on the electrophoretogram, correct?

248 MR. MATHESON:

For those items under the 84-A and 84-B, that's correct. They're--roughly where they are don't take into account the curve and they don't take into account the intensity differences.

249 MR. BLASIER:

Right. And if we adjusted the curve, those bands under 84-A and 84-B would line up with the standard B bands and the standard BA, correct?

250 MR. MATHESON:

That is correct.

251 MR. BLASIER:

Next slide, please.

252 MR. BLASIER:

Now--and as you read in your report, the fingernail--I'm sorry--as you reported in your report, your reading of that test was that the--both fingernails from both hands were a type B, correct?

253 MR. MATHESON:

That's correct.

254 MR. BLASIER:

And that was slide P. Let's go to Q. Now we're back to our standard BA in Q. Let's go to R. Let's go to s.

255 MR. BLASIER:

Part of your testimony the other day concerned the manner in which a BA can degrade, correct?

256 MR. MATHESON:

That is correct.

257 MR. BLASIER:

Now, if you have a BA, you would have the banding pattern that we have up on slide S, correct?

258 MR. MATHESON:

Again, not taking into account the intensity differences, but that's the locations of the bands.

259 MR. BLASIER:

Now, I want you to assume for purposes of the hypothetical that the degradation that occurs when a BA degrades involves bands disappearing from the top down.

260 MR. GOLDBERG:

Improper hypothetical. No foundation for it.

261 THE COURT:

Sustained. Rephrase the question.

262 MR. BLASIER:

Mr. Matheson, let me ask you about some of the scientific literature. You referred to an article by Grunbaum and Zajac in your direct testimony. Do you recall that?

263 MR. MATHESON:

I was directed to that, yes.

264 MR. BLASIER:

There is other literature on the EAP systems, correct?

265 MR. MATHESON:

Yes.

266 MR. BLASIER:

And you're familiar with that other literature; are you not?

267 MR. MATHESON:

I've read some of them, yes.

268 MR. BLASIER:

And you were provided with a copy of a number of different articles the other day; were you not?

269 MR. MATHESON:

No, I was not.

270 MR. BLASIER:

Oh. Are you familiar with an article by Dr. George Sensabaugh entitled "the utilization of polymorphic enzymes in forensic science"?

271 MR. MATHESON:

I would like to see it, please.

272 MR. BLASIER:

Sure.

273 MR. MATHESON:

I have seen this, yes.

274 MR. BLASIER:

And have you relied upon that in the way you evaluate the EAP system?

275 MR. GOLDBERG:

It's overbroad, the question as phrased.

276 THE COURT:

Overruled.

277 MR. MATHESON:

I have read this article and there is information in it that--regarding the EAP in general, is one of many references that I have referenced in relation to the EAP system.

278 MR. BLASIER:

So it's one that you have considered and referred to?

279 MR. MATHESON:

I have considered some of the infor--

280 MR. GOLDBERG:

Vague as to consider; in what, in rendering an opinion?

281 THE COURT:

We'll get there in a second.

282 MR. BLASIER:

Did you do any research at all before your testimony on the rate at which, according to the scientific literature, a BA degrades to a B?

283 MR. MATHESON:

I have done some reading on that, yes.

284 MR. BLASIER:

What things did you read?

285 MR. MATHESON:

Well, there was three or four articles that I read that related to degradation of EAP in general and many of them reference one particular way that it degrades.

286 MR. BLASIER:

What articles did you read?

287 MR. MATHESON:

If I could--I think a reference would give you a couple of them.

288 MR. BLASIER:

Yes.

289 (Brief pause.)
290 MR. MATHESON:

As mentioned earlier, one of the ones that I've read is this article that you presented before me. I also read an article entitled "Erythro Acid Phosphatase and Bloodstains" by Wraxall and Emes.

291 MR. BLASIER:

When you say I showed you an article, that's it, isn't it?

292 MR. MATHESON:

Yes, it is. And I also referenced a book called "The Source Book," "Source Book and Forensic Serology, Immunology and Biochemistry," and I also read portions from a book called "Forensic Science Handbook" by Richard Saferstein.

293 MR. BLASIER:

Are you familiar with a technical note by a T.E. Yeshion, Y-E-S-H-I-O-N, titled "Thermal Degradation of Erythro Acid Phosphatase Isoenzymes in a Case Sample"?

294 MR. MATHESON:

I read that one the other day, yes.

295 MR. BLASIER:

And am I handing you what appears to be that article?

296 MR. MATHESON:

Yes, it appears to be.

297 MR. BLASIER:

And have you ever reviewed and considered an article by R.A. Fisher and Harry Harris titled "studies on the separate isoenzymes of red cell acid phosphatase phenotypes A and B"?

298 MR. MATHESON:

Again, I would like to see it, please.

299 (Brief pause.)
300 MR. MATHESON:

This one does not look familiar to me.

301 MR. GOLDBERG:

May I just have one moment to take a look at this?

302 (Brief pause.)
303 MR. BLASIER:

Now, other than the Grunbaum article--incidentally, let me show you a copy of that and ask if this is the article that you testified about the other day.

304 MR. MATHESON:

Yes, it appears to be.

305 MR. BLASIER:

Other than the Wraxall article, the Yeshion article, the Grunbaum article and the Sensabaugh article, are there any other scientific articles that you have reviewed specifically to look for how a BA degrades?

306 MR. GOLDBERG:

It's vague as to time.

307 THE COURT:

Overruled.

308 MR. BLASIER:

In preparation for this case.

309 MR. MATHESON:

I believe I mentioned two other references, something that is commonly called "source book" and another textbook by Saferstein.

310 MR. BLASIER:

Now, I was talking about articles devoted to that topic specifically rather than textbooks.

311 MR. MATHESON:

Oh, I'm sorry. To the best of my recollection, that's it.

312 MR. BLASIER:

Okay. What do those articles say about the rate at which a BA degrades?

313 MR. MATHESON:

Rate being the amount of time it takes or--

314 MR. BLASIER:

No. Which bands disappear first?

315 MR. MATHESON:

Most of the articles make reference to the fact that degradation does in fact occur and that as a rule, it tends to go from the anodal or the faster bands down towards the cathodal or slower bands.

316 MR. BLASIER:

Would you agree that those articles stand for the proposition that at the first stage of degradation, you lose the a-2 band?

317 MR. GOLDBERG:

It's overbroad as to those articles.

318 THE COURT:

Sustained.

319 MR. BLASIER:

The articles we're been talking about.

320 MR. GOLDBERG:

It's still overbroad.

321 THE COURT:

Sustained.

322 MR. BLASIER:

Sensabaugh, Zajac, Yeshion and Wraxall, those four articles, would you agree that the results of their scientific tests are that the first thing to disappear is the a-2?

323 MR. GOLDBERG:

Assumes that they all did scientific tests, a fact not in evidence.

324 THE COURT:

Overruled.

325 MR. MATHESON:

They do tend to point out or point out that the most labile or the first one to go is in fact that fastest a-2 band.

326 MR. BLASIER:

Next slide. I'm sorry. Next slide. This is p.

327 MR. BLASIER:

So after that first stage of degradation, your BA is going to look like the right-hand column of slide t according to the scientific literature, correct, this scientific literature?

328 MR. MATHESON:

According to those articles, that's the degradation route that they have seen.

329 MR. BLASIER:

Now, those articles also state, do they not, that the next stage of degradation is, you lose the b-2 band?

330 MR. GOLDBERG:

Well, it assumes that there's only one degradation route, a fact not in evidence.

331 THE COURT:

Overruled. Talking--this is in reference to these articles?

332 MR. BLASIER:

Yes.

333 MR. MATHESON:

That's the general route that those articles reference, yes.

334 MR. BLASIER:

Okay. The next slide, please. This is what? Q? U.

335 MR. BLASIER:

So you would agree, would you not, that these articles indicate that the next stage of degradation you would see if you had a BA that was degrading, you would see two bands, the b-1 and the a-1 band?

336 MR. MATHESON:

Under the conditions that those studies were run in, yes, that is the general route of degradation.

337 MR. BLASIER:

Now, those studies further indicate, do they not, that the next thing to go when it degrades is the a-1 band, correct?

338 MR. MATHESON:

That's the general route of that form of degradation, yes.

339 MR. BLASIER:

Next slide, please. Is it P?

340 MR. BLASIER:

So, therefore, according to these articles, a BA that's degrading will ultimately, before the last band disappears, have the b-1 band there, correct?

341 MR. MATHESON:

Again, according to the conditions that those samples were treated and under the conditions they are run, that is the degradation route that's referred to.

342 MR. BLASIER:

Would you agree that under that degradation route, you never have the pattern of a BA that's degraded that has both the b-1 and the b-2 bands without the a-1 band?

343 MR. MATHESON:

Again, given the things I mentioned before, the conditions of the samples in those studies and the system they used for identifying it, that is true.

344 MR. BLASIER:

And in this case, your test results showed both the b-1 and the b-2 band without the a-1 band, didn't they?

345 MR. MATHESON:

That's correct.

346 MR. BLASIER:

So under this scientific literature, if this BA was a degraded--I'm sorry--if your B under the fingernails was a degraded BA, it wouldn't look like the results you got, would it?

347 MR. MATHESON:

If my sample or the samples that I analyzed were under those conditions in those studies and run in the same way, that's correct.

348 MR. BLASIER:

Can you cite me to a single scientific article that states that the degradation route taken by a BA when it degrades would ever get you to the point where you're going to have a b-1 and a b-2 without the a-1?

KEY QUOTE
349 MR. MATHESON:

And we're talking specifically about articles at this point?

350 MR. BLASIER:

Yes.

351 MR. MATHESON:

No, I can not.

352 MR. BLASIER:

I think you said also--

353 MR. BLASIER:

You can turn that off now.

354 MR. BLASIER:

Now, none of those articles that we--that we've talked about--the reason cited in those articles for doing these studies is to find out how a BA degrades, correct? That was one of the purposes of all of these articles?

355 MR. MATHESON:

Well, it's known that it does degrade. So, yes, the purpose of those articles potentially among other things, because they include other bits of information, is to determine one of the ways that B or an EAP will degrade.

356 MR. BLASIER:

And all of those articles talk about, you could misinterpret a BA or b--I'm sorry--you could misinterpret a BA for a B if you made a reading based on just that b-1 band at the end, correct?

357 MR. MATHESON:

That's correct.

358 MR. BLASIER:

And they all say that, therefore, you shouldn't make any reading at all if all you have is one b-1 band, correct?

359 MR. MATHESON:

That's correct.

360 MR. BLASIER:

But they say that you will not have a mistyping where you have a b-1 and a b-2 band because that would not be a degraded BA, correct?

361 MR. MATHESON:

I don't believe they all say that, no.

362 MR. BLASIER:

Can you cite--show me one that doesn't say that?

363 MR. MATHESON:

It's going to take me a few minutes to look. I believe they say that that are things that may happen, but--

364 THE COURT:

Well, counsel, let's move on. We're not going to sit here and read articles.

365 MR. BLASIER:

They do say that you can accurately read a BA and a B as long as there are two bands present. In other words, you can read a B if there are two bands present accurately, correct?

366 MR. GOLDBERG:

Incomplete as to what conditions.

367 THE COURT:

Sustained. Actually when you say "they," I think you need to specify which articles.

368 MR. BLASIER:

Do any of the articles say that you should not call a B where you have both the b-1 and b-2 bands?

369 MR. MATHESON:

No, they don't.

370 MR. BLASIER:

Do they all say that you shouldn't make any call at all if you only have one band?

371 MR. MATHESON:

It's my understanding, yes.

372 MR. BLASIER:

Now, I wanted--you also testified that item 42 had the same appearance, the same reading as the fingernails, correct?

373 MR. MATHESON:

No, I don't believe I said they had the same reading or the same appearance.

374 MR. BLASIER:

Can we go back to slide A?

375 MR. BLASIER:

Now, you recognize slide a up there as being the one we were talking about with the standard?

376 MR. MATHESON:

Yes, I do.

377 MR. BLASIER:

Would you agree that the lane next to the standard that we used--

378 MR. BLASIER:

In fact, why don't you go to the next slide, slide B.

379 MR. BLASIER:

--that the lane just to the right of the standard lane is item--I'm sorry. Actually it's--to the left of the box is item 42?

380 MR. MATHESON:

Yes. Adjacent to the other standard.

381 (Discussion held off the record between the Deputy District Attorney and Defense counsel.)
382 MR. BLASIER:

Now, let me show you a photograph. Does this appear to be a photograph of that same electrophoretogram?

383 MR. MATHESON:

Yes, it does. It appears to be an enlargement of it.

384 MR. BLASIER:

And item 42 appears in that electrophoretogram as it does in the slide on the projector, correct?

385 MR. MATHESON:

It was in the same location in the--it's much easier to read in the photograph.

386 MR. BLASIER:

Now, there is--you can pick up a little bit more in the photograph than you can on the slide, correct?

387 MR. GOLDBERG:

Object to the phrase "little bit more."

388 THE COURT:

Rephrase it.

389 MR. BLASIER:

You can see some very, very faint banding patterns under 42 that doesn't completely show up in the slide, correct?

390 MR. MATHESON:

That's correct.

391 MR. BLASIER:

Maybe we can try to put this on the elmo to illustrate that.

392 THE COURT:

I think that's one we may have to have both up and have the jury look at the blow-up.

393 MR. BLASIER:

That's fine. Can we try this, then--

394 THE COURT:

Yeah, try it, but I'm just trying to save some time here.

395 MR. BLASIER:

In fact, let me--

396 MR. BLASIER:

Okay. We can see it a little bit better this way; would you agree?

397 MR. MATHESON:

A little bit better.

398 MR. BLASIER:

And would you agree that the lane for item 42 appears to have three very faint bands corresponding to b-1, a-1 and b-2, very faint?

399 MR. MATHESON:

Well, the b-1 and b-2, I believe I can see what are banding areas, very kind of fuzzy, difficult to read. There is kind of a brightish cloud in the a-1 region.

400 MR. BLASIER:

And the photograph of 1141-A1. Now, the very faint--can you see behind you on the screen up there? The very faint, fuzzy a-1 band is what I've got the light on, correct?

401 MR. GOLDBERG:

That misstates the evidence.

402 MR. BLASIER:

Well--

403 THE COURT:

Overruled.

404 MR. BLASIER:

Right about there (Indicating)?

405 MR. MATHESON:

Well, there is some florescence in that area. It's not even really what I would call a band.

406 MR. BLASIER:

It's not--and that's one of the reasons that this was an inconclusive; is because those are not sufficiently well-defined bands to really make a type on, correct?

407 MR. GOLDBERG:

"those" is overbroad. Which of--

408 THE COURT:

Overruled.

409 MR. BLASIER:

The faint markings you see in lane 42.

410 MR. MATHESON:

It was called inconclusive, right, because the bands that I visualized in there just were not what I would call clear-cut bands.

411 MR. BLASIER:

And let me show you a photograph of the fingernail slide. Does that appear to be a similar photograph?

412 MR. MATHESON:

Yes, it does.

413 MR. BLASIER:

And this would be 1141-J1. And I would like to put both of these on at the same time.

414 (Brief pause.)
415 MR. BLASIER:

Now, you see the two photographs that we have on the projector?

416 MR. MATHESON:

Yes, I do.

417 MR. BLASIER:

And the 42 again is the one that I have the laser light on now up on the big projector. Can you see that behind you?

418 MR. MATHESON:

I'm sorry. Can you repeat the question?

419 MR. BLASIER:

Yeah. The light that I'm using on the large projector up above you is the 42 lane, correct?

420 MR. MATHESON:

Yes, it is.

421 MR. BLASIER:

And the lanes over here--

422 MR. BLASIER:

Oh, good, we've got the arrow. Can we move the arrow over to 84-A and b? Right there.

423 MR. BLASIER:

Those are the banding patterns from the fingernails, correct?

424 MR. MATHESON:

Yes. That's correct.

425 MR. BLASIER:

And could we put an arrow over by 42 as well? Can we affix one there?

426 MR. BLASIER:

Would you agree that the banding patterns for 84-A and B are much more distinctive than 42?

427 MR. MATHESON:

Yes.

428 MR. BLASIER:

And that's why you read 84-A and B and did not report anything other than inconclusive for 42?

429 MR. MATHESON:

That's one of the reasons, yes.

430 MR. BLASIER:

Could we print that up? The print will be 1142.

431 THE COURT:

All right. 1142. Print of items 42 and 84.

432 (Deft's 1142 for id = print of items 42 and 84)
433 MR. GOLDBERG:

What was the printout?

434 THE COURT:

It was the two electrophoretograms of 42 and 84 side by side with arrows.

435 MR. BLASIER:

Now, your testimony the other day about 42 was to the effect that, since 42 was preserved under similar conditions to 84-A and B, therefore, you can draw some kind of an analogy between the results of 42 and the results of 84, correct?

436 MR. GOLDBERG:

Misstates the testimony.

437 THE COURT:

Overruled.

438 MR. MATHESON:

I believe environmental conditions and the like was one of the things that we mentioned that is used in the total consideration of everything.

439 MR. BLASIER:

Now, one of the--the photographs that you looked at of Nicole Brown Simpson showed one of her hands under her body and one of her hands up exposed to the air, correct?

440 MR. MATHESON:

Yes.

441 MR. BLASIER:

So those two were not under the same conditions in terms of drying or being in a pool of blood, were they?

442 MR. MATHESON:

Not exactly the same, no.

443 MR. BLASIER:

And would you agree that if you follow the scientific literature that I've shown to you and that you've reviewed, that the blood under Nicole Brown's Simpson's fingernails cannot be a BA?

444 MR. GOLDBERG:

Assuming an improper hypothetical.

445 THE COURT:

Overruled.

446 MR. MATHESON:

I'm sorry. Could you read that or repeat that, please?

447 MR. BLASIER:

Would you agree that under the scientific literature that we've reviewed here, that the blood under Nicole Brown Simpson's fingernails cannot be a degraded BA?

448 MR. MATHESON:

If you look strictly at the literature and if the conditions under the fingernails are the same as the way those studies were done in the literature and the technique used to identify it was the same as I used in my testing, then it does not follow that degradation route, that's correct.

449 MR. BLASIER:

And if that's true, then it has to have come from somebody else, correct?

450 MR. GOLDBERG:

Improper hypothetical.

451 THE COURT:

Overruled.

452 MR. MATHESON:

Given all of the considerations that I mentioned, they would all have to be the same, and if--like I said, in fact if it did follow that same degradation route, then it would have to be a B and it would have to come from somebody else.

453 MR. BLASIER:

Now, if you have test results that you think might be wrong or ambiguous, what are you supposed to do as a scientist?

454 MR. MATHESON:

I would not report them if they were wrong or ambiguous.

455 MR. BLASIER:

If you thought that the results were wrong, would you redo the test?

456 MR. MATHESON:

Depends on what other tests were available to me.

457 MR. BLASIER:

Now, looking at EAP--well, if you do a PGM test or a DNA test, you're not looking at the same things as you're looking at in EAP, are you?

458 MR. MATHESON:

You're potentially looking at the same thing, but there are other factors, that's correct.

459 MR. BLASIER:

Nothing that you do other than an EAP test is going to give you an EAP reading, correct?

460 MR. MATHESON:

Well, that's correct, yes. I mean, only an EAP test is going to give you an EAP result.

461 MR. BLASIER:

So the only way that you could double-check that EAP test would be to do another EAP test, correct?

462 MR. MATHESON:

Well, theoretically, if they knew what caused the EAP type at the DNA level, you could do it that way. I don't believe there's a standard test for that right now. So the only way to reconfirm that result would be to run the exact same test again.

463 MR. BLASIER:

These fingernail scrapings were sent back to you by the Department of Justice for the purposes of doing another EAP test, weren't they?

464 MR. GOLDBERG:

That misstates the testimony, assumes facts not in evidence.

465 THE COURT:

Sustained.

466 MR. BLASIER:

At some point, you sent them to DOJ and they sent them back, didn't they?

467 MR. MATHESON:

Yes, that's true.

468 MR. BLASIER:

What was the purpose for them sending it back?

469 MR. MATHESON:

Because it's our evidence. The evidence belongs back here when they're done completing it so it could become part of the rest of the case.

470 MR. BLASIER:

Did you ever consider doing a retest of those fingernail scrapings, an EAP test, to see whether your original results were wrong?

471 MR. MATHESON:

Did I consider it?

472 MR. BLASIER:

Yes.

473 MR. MATHESON:

I considered it, yes.

KEY QUOTE
474 MR. BLASIER:

You wanted to do it, didn't you?

475 MR. MATHESON:

I felt that there was other tests that could give more information. I did not want to consume any more of the sample just to repeat the exact same thing again.

476 MR. BLASIER:

So you've done no retesting to demonstrate whether this EAP is anything other than a B or someone other than Mr. Simpson, correct?

477 MR. MATHESON:

There has never been any other testing I--excuse me. I have not repeated or done any other EAP testing, that's correct.

478 MR. BLASIER:

No further questions.

Temperature

tense

Key Quotes (4)

Robert Blasier
Can you cite me to a single scientific article that states that the degradation route taken by a BA when it degrades would ever get you to the point where you're going to have a b-1 and a b-2 without the a-1?
The climax of the cross — Matheson is forced to answer 'No, I can not,' undermining the prosecution's alternative explanation for the type B result under Nicole's fingernails.
Gregory Matheson
if it did follow that same degradation route, then it would have to be a B and it would have to come from somebody else.
Matheson concedes the logical conclusion of Blasier's argument: if the science holds, the blood under Nicole's fingernails came from someone who is not O.J. Simpson.
Gregory Matheson
I considered it, yes... I felt that there was other tests that could give more information. I did not want to consume any more of the sample just to repeat the exact same thing again.
Matheson admits he wanted to retest the fingernail scrapings but chose not to — leaving his ambiguous results unchallenged and potentially exculpatory evidence unexamined.
Robert Blasier
And the scientific term for that is schmutz, isn't it? Actually, I don't think I've heard that term, but-- Mr. Scheck told me.
Rare moment of levity during an otherwise dense technical examination; reveals that Scheck (co-counsel) coached Blasier on lab vocabulary.

Evidence (9)

People's 202
Chart prepared by the D.A.'s office showing serological results including item 42
discussed
Defense 1141-A through Z
Slide presentation illustrating EAP electrophoretogram band patterns and degradation routes
introduced and used extensively during cross-examination
Defense 1142
Printed side-by-side photograph of electrophoretograms for items 42 and 84-A/B with arrows
introduced
Informal
Item 42 — blood sample taken from area under Nicole Brown Simpson's body
discussed; reported as inconclusive by Matheson
Informal
Items 84-A and 84-B — fingernail scrapings from Nicole Brown Simpson's left and right hands
discussed; reported as type B by Matheson
Informal
Grunbaum and Zajac article on EAP degradation
discussed; used on direct and referenced in cross
+ 3 more

Notable Exchanges (4)

Robert BlasierGregory Matheson
Blasier systematically walked Matheson through four scientific articles on EAP degradation, establishing that the degradation pathway described (a-2 disappears first, then b-2, then a-1, leaving only b-1) never produces the pattern Matheson actually observed (b-1 and b-2 without a-1). Matheson could not cite a single article contradicting this.
methodical and devastating
Robert BlasierGregory Matheson
Blasier established that in hundreds of prior cases where EAP came back type B incriminating a defendant, Matheson never added the BA disclaimer he now offers in this case — he only added it when BA would serve as an exclusion.
revealing
Robert BlasierGregory Matheson
Blasier elicited that Matheson considered retesting the fingernail scrapings via EAP but declined, leaving no second confirmation of his ambiguous B result.
strategic
Robert BlasierGregory Matheson
Side-by-side comparison of photographs for item 42 (inconclusive) and items 84-A/B (typed as B), with Matheson agreeing the fingernail bands were 'much more distinctive' — undermining any analogy between the two samples.
revealing

Light Moments (1)

Robert Blasier
Blasier asked if the technical term for artifact dots on the gel was 'schmutz,' Matheson said he'd never heard the term, and Blasier quipped 'Mr. Scheck told me.'

Credibility Attacks (4)

⚔ Gregory Matheson
prior inconsistent practice / selective application of disclaimer
Blasier established that Matheson had typed samples as EAP B in approximately 750 prior cases incriminating defendants without ever noting the BA disclaimer — he only raises the BA alternative in this case where doing so would help the prosecution, not the defense.
⚔ Gregory Matheson
contradiction by scientific literature
Blasier used four peer-reviewed articles that Matheson himself relied upon to show that a degraded BA would never produce the b-1/b-2 pattern without a-1 that Matheson observed. Matheson could not cite any article supporting his alternative theory.
⚔ Gregory Matheson
failure to retest
Matheson admitted he considered retesting the fingernail scrapings for EAP but chose not to, leaving his ambiguous results without independent confirmation despite the stakes of the case.
⚔ Gregory Matheson
anecdotal basis for testimony
Matheson acknowledged his 'personal experience' regarding BA degradation is based on casework observations he never published, never systematically tracked, and which contradict the published literature.

Witness Demeanor

(Brief pause.) [witness checks records for EAP case count]
(The witness complies.) [looking up population statistics]
(Brief pause.) [reviewing articles presented by defense]

Objections

18 objections (5 sustained, 12 overruled)
Proceeding 5912 • 478 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 4, 1995 📄 Cross-examination of Gregory M
MAY 4, 1995 KRT DvH TD